{Reference Type}: Case Reports
{Title}: Quetiapine-related acute lung injury: A case report.
{Author}: Huang YX;He GX;Zhang WJ;Li BW;Weng HX;Luo WC;Huang YX;He GX;Zhang WJ;Li BW;Weng HX;Luo WC;
{Journal}: World J Clin Cases
{Volume}: 10
{Issue}: 7
{Year}: Mar 2022 6
{Factor}: 1.534
{DOI}: 10.12998/wjcc.v10.i7.2216
{Abstract}: <B>BACKGROUND: </B>Quetiapine, known as a non-classical antipsychotic drug, is frequently used for the treatment of mental diseases, such as schizophrenia, bipolar disorder, and major depressive disorder. Acute lung injury, a rarely reported side effect of quetiapine, is described in this case report.<BR><B>METHODS: </B>Due to terminal delirium, a 66-year-old man took a large dose of quetiapine and then developed severe pulmonary disease. His symptoms were not resolved after routine treatment, such as antibiotics, diuretic, and supportive therapies. Quetiapine-related acute lung injury was therefore suspected and hormonal therapy was initiated. Subsequently, his symptoms were alleviated and the radiological results improved dramatically.<BR><B>CONCLUSIONS: </B>Our findings in the present report highlight a potential adverse effect of quetiapine, drug-related acute lung injury, which deserves awareness in clinical practice.